CHR-6494
≥98%
- Product Code: 100072
CAS:
1333377-65-3
Molecular Weight: | 292.34 g./mol | Molecular Formula: | C₁₆H₁₆N₆ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
CHR-6494 is primarily investigated for its potential in cancer therapy, particularly as an inhibitor of histone deacetylase (HDAC) enzymes. By targeting HDACs, it plays a role in regulating gene expression, which can lead to the suppression of tumor growth and the induction of apoptosis in cancer cells. Its application is significant in research focused on developing treatments for various cancers, including hematological malignancies and solid tumors. Additionally, it is studied for its potential to enhance the efficacy of other anticancer agents when used in combination therapies.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿4,104.00 |
+
-
|
0.010 | 10-20 days | ฿7,740.00 |
+
-
|
CHR-6494
CHR-6494 is primarily investigated for its potential in cancer therapy, particularly as an inhibitor of histone deacetylase (HDAC) enzymes. By targeting HDACs, it plays a role in regulating gene expression, which can lead to the suppression of tumor growth and the induction of apoptosis in cancer cells. Its application is significant in research focused on developing treatments for various cancers, including hematological malignancies and solid tumors. Additionally, it is studied for its potential to enhance the efficacy of other anticancer agents when used in combination therapies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :